Assessment of Pain in People With Thalassemia
NCT00872339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 252
Last updated 2014-06-05
Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. People with thalassemia often experience pain, but the exact sources and prevalence of pain remain unknown. This study will examine the prevalence and severity of pain in people with thalassemia who are treated with regular blood transfusions and people with thalassemia who are not treated with regular blood transfusions.
Conditions
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Carelon Research
lead OTHER
Principal Investigators
-
Jeanne Boudreeaux, MD · Children's Healthcare of Atlanta
-
Ellis Neufeld, MD · Boston Children's Hospital
-
Alexis Thompson, MD · Children's Memorial Hospital of Chicago
-
Brigitta Mueller, MD · Baylor College of Medicine at Houston
-
Dru Foote, RN, NP · Children's Hospital and Research Institute of Oakland
-
Patricia Giardina, MD · Weill Medical College of Cornell
-
Janet Kwiatkowski, MD · Children's Hospital of Philadelphia
-
Nancy Olivieri, MD · Toronto General Hospital
Eligibility
- Min Age
- 12 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Long Term Outcomes in β Thalassemia Major
NCT02307786 ·Status: COMPLETED
-
Bone Marrow for Hemoglobinopathy Research
NCT00669305 ·Status: COMPLETED
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
Long-term Clinical Study of CN128 in Thalassemia Patients
NCT04614779 ·Status: COMPLETED ·Phase: PHASE2
-
Atrial Fibrillation in Beta-Thalassemia
NCT05508932 ·Status: RECRUITING
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia
NCT06210139 ·Status: COMPLETED
-
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512226 ·Status: COMPLETED ·Phase: NA
-
Perceptions of Thalassemia Major in Singapore: An Exploratory Study of Stigma
NCT01129076 ·Status: COMPLETED
-
Allograft for Sickle Cell Disease and Thalassemia
NCT02038478 ·Status: WITHDRAWN ·Phase: PHASE2
-
Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia
NCT05494333 ·Status: UNKNOWN
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
Assessment of Quality of Life in Thalassemic Patients at Assiut University Hospital: A Single-center Experience
NCT05790980 ·Status: UNKNOWN
-
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
NCT06568926 ·Status: RECRUITING ·Phase: NA
-
The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00971698 ·Status: COMPLETED
-
Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
NCT00480506 ·Status: COMPLETED
-
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
NCT00103753 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Cognitive Functions, Psychological Symptoms, and Quality of Life Among B Thalassemia Patients and Their Clinical Correlates.
NCT05105659 ·Status: UNKNOWN
-
Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital
NCT03161899 ·Status: COMPLETED
-
Reproductive Capacity and Iron Burden in Thalassemia
NCT02308904 ·Status: COMPLETED ·Phase: NA
-
Natural History of Sickle Cell Disease
NCT00081523 ·Status: RECRUITING
-
5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
NCT00005934 ·Status: COMPLETED ·Phase: PHASE2
-
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
NCT00029380 ·Status: COMPLETED ·Phase: PHASE2